Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 38Breast Neoplasms 31Lung Neoplasms 25Colorectal Neoplasms 15Prostatic Neoplasms 13Pancreatic Neoplasms 11Ovarian Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Head and Neck Neoplasms 9Sarcoma 8Colonic Neoplasms 8Carcinoma, Hepatocellular 8Uterine Cervical Neoplasms 7Glioma 7Esophageal Neoplasms 7Melanoma 6Lymphoma 6Endometrial Neoplasms 6Neoplastic Cells, Circulating 5Multiple Myeloma 5Brain Neoplasms 5Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Neoplasm, Residual 4Gastrointestinal Neoplasms 4Carcinoma, Squamous Cell 4Carcinoma, Renal Cell 4Adenocarcinoma 4Thrombosis 3Rectal Neoplasms 3

Interventions

Cisplatin 12pembrolizumab 11Magnetic Resonance Spectroscopy 11Specimen Handling 10Paclitaxel 6Platinum 5Cyclophosphamide 51,2-diaminocyclohexaneplatinum II citrate 5fludarabine 4durvalumab 4cemiplimab 4Radiotherapy, Intensity-Modulated 4Radiotherapy 3Pemetrexed 3Oxaliplatin 3Nivolumab 3Fluorouracil 3Cetuximab 3Carboplatin 3Biopsy 3poly ICLC 2fludarabine phosphate 2cabozantinib 2atezolizumab 2Radiation 2Ipilimumab 2Interviews as Topic 2Heavy Ion Radiotherapy 2Gemcitabine 2Drug Therapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Carcinoma × Blood Specimen Collection × Clear all
NCT00349830 2026-02-10

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

Stanford University

Recruiting
2,000 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡